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Abstract
Background: Mutations in either of two genes comprising the STSL locus, ATP-binding cassette (ABC)-transporters
ABCG5 (encoding sterolin-1) and ABCG8 (encoding sterolin-2), result in sitosterolemia, a rare autosomal recessive
disorder of sterol trafficking characterized by increased plasma plant sterol levels. Based upon the genetics of
sitosterolemia, ABCG5/sterolin-1 and ABCG8/sterolin-2 are hypothesized to function as obligate heterodimers. No
phenotypic difference has yet been described in humans with complete defects in either ABCG5 or ABCG8. These
proteins, based upon the defects in humans, are responsible for regulating dietary sterol entry and biliary sterol secretion.
Methods: In order to mimic the human disease, we created, by a targeted disruption, a mouse model of sitosterolemia
resulting in Abcg8/sterolin-2 deficiency alone. Homozygous knockout mice are viable and exhibit sitosterolemia.
Results: Mice deficient in Abcg8 have significantly increased plasma and tissue plant sterol levels (sitosterol and
campesterol) consistent with sitosterolemia. Interestingly, Abcg5/sterolin-1 was expressed in both liver and intestine in
Abcg8/sterolin-2 deficient mice and continued to show an apical expression. Remarkably, Abcg8 deficient mice had an
impaired ability to secrete cholesterol into bile, but still maintained the ability to secrete sitosterol. We also report an
intermediate phenotype in the heterozygous Abcg8+/- mice that are not sitosterolemic, but have a decreased level of
biliary sterol secretion relative to wild-type mice.
Conclusion: These data indicate that Abcg8/sterolin-2 is necessary for biliary sterol secretion and that loss of Abcg8/
sterolin-2 has a more profound effect upon biliary cholesterol secretion than sitosterol. Since biliary sitosterol secretion
is preserved, although not elevated in the sitosterolemic mice, this observation suggests that mechanisms other than by
Abcg8/sterolin-2 may be responsible for its secretion into bile.
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Absorption of dietary cholesterol from the intestine is an
important part of cholesterol homeostasis and represents
the initial step that allows dietary cholesterol to exert its
metabolic effects. A typical western diet contains relatively
equal amounts of cholesterol and non-cholesterol sterols,
mainly plant sterols, of which about 55% of the dietary
cholesterol is absorbed and retained compared to ~1% of
the dietary non-cholesterol sterols [1-3]. Schoenheimer
recognized more than 75 years ago that only cholesterol,
not non-cholesterol sterols, is absorbed in the intestine,
although the exact molecular mechanisms by which pref-
erential cholesterol absorption occurs has not been fully
elucidated [4]. Similarly, although the liver secretes free
cholesterol into bile, it can preferentially excrete non-cho-
lesterol sterols into bile and the mechanism(s) of this
process has yet to be elucidated as well. Only recently,
through the study of a rare human disease, have clues to
this process been revealed.
Sitosterolemia (MIM 210250, also known as phytostero-
lemia) is a rare autosomal, recessively inherited disorder
characterized by elevated blood and tissue plant sterol lev-
els [5]. Affected individuals can develop tendon and/or
tuberous xanthomas, hemolytic episodes, arthralgias,
arthritis, and premature atherosclerosis [6,7]. Sitostero-
lemic patients have diagnostically elevated plasma plant
sterol levels (for example, sitosterol, campesterol, stigmas-
terol, and avenosterol, etc.) and their 5-saturated stanol
metabolites, particularly sitostanol, with normal or only
moderately increased cholesterol levels. Clinical studies
have shown that affected individuals hyperabsorb all die-
tary sterols (thus have lost the ability to restrict the sterol
species absorbed) and have lost the ability to excrete ster-
ols into bile [8,9]. Infusion of sitosterol and cholesterol
into normal individuals leads to a rapid and preferential
excretion of sitosterol into bile, but in sitosterolemic indi-
viduals biliary sterol secretion is almost absent [7,9]. Pre-
vious studies on sitosterolemia have suggested a defect
involving a putative sterol 'transporter' expressed in the
intestinal brush border and/or the hepatic canalicular
membrane [10,11]. Genetic analyses of sitosterolemia
pedigrees allowed the mapping of the STSL locus to
human chromosome 2p21, between D2S2294 and
D2S2298 [12,13]. By using positional cloning procedures
or by screening for genes induced by exposure to LXR ago-
nists, two groups identified not one but two genes, ABCG5
and ABCG8, which encode the proteins sterolin-1 and
sterolin-2, mutations of which cause sitosterolemia [14-
16]. Interestingly, complete mutation in either ABCG5
alone or ABCG8 alone is not only necessary, but sufficient
to cause the disease [14]. To date, no patient with sitoste-
rolemia has been identified with mutations in both genes.
Based upon these data, and the similarity of the clinical
and biochemical phenotype, sterolin-1 and sterolin-2 are
hypothesized to function as obligate heterodimers. This is
also supported by the fact that each of these proteins is a
'half-transporter', containing six transmembrane
domains, and not the classical 12 transmembrane charac-
teristic of functional ABC transporters. The exact function
of these two proteins still remains unknown but recent
studies have shown that overexpression of ABCG5/
ABCG8 in a transgenic mouse model results in an
increased biliary cholesterol concentration and a 50%
reduction in the fractional absorption of dietary choles-
terol [17]. It has been suggested that ABCG5 and ABCG8
act as mutual chaperones for both maturation and correct
apical targeting. Co-expression of both was required for
apical trafficking in a polarized cell line, as well in vivo
using Abcg5/Abcg8 double-knockout mice [18,19]. How-
ever, no functional assay has yet been developed to dem-
onstrate whether or not the two half-transporters function
as homo- or heterodimers and whether they selectively
pump sterols. Likewise, the cellular localization of these
two proteins has yet to be shown in a model deficient in
either Abcg5 or Abcg8 alone. A mouse model disrupting
both Abcg5 and Abcg8 simultaneously results in a pheno-
type similar to that of the human disease [20]. However,
it is important to point out that the human disease is
caused by complete mutation in one or the other gene,
but not both simultaneously.
We hypothesized that disruption of only one of the half-
transporters would result in sitosterolemia and selective
loss of either sterolin may show a differential effect on the
biliary secretion of sterols or intestinal absorption of ster-
ols. These studies are difficult to test in humans, as the tar-
get organs are relatively inaccessible. In order to test this
hypothesis, we report a mouse model that has a selective
genetic mutation of Abcg8. Mice homozygous for Abcg8
loss exhibit many of the characteristics of the human dis-
ease sitosterolemia. In addition, we report studies of bil-
iary sterol secretion that show that despite forced
secretion, Abcg8-deficient animals cannot secrete
cholesterol into bile, although sitosterol secretion seemed
unaffected.
Methods
Targeting vector construction and generation of knockout 
mice
A mouse genomic bacterial artificial chromosome (BAC)
library (CitbCJ7, ES cell line/129Sv, Research Genetics,
Inc., Huntsville, AL, USA) was screened by using primers
designed from the sequences of mouse Abcg5 and Abcg8
cDNA as previously reported [21]. A positive BAC clone
was used as a template to amplify genomic DNA frag-
ments of Abcg8. Long-fragment polymerase chain reaction
(PCR) was performed using Expanded Long Template
PCR system kit (Roche Applied Science, Indianapolis, IA,
USA). An approximately 4.5 kb 'long-arm' genomic frag-Page 2 of 21
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inserted into the Pml I restriction-cloning site A of
OSDUPDEL vector. The 'short-arm' genomic fragment,
containing partial exon 4 to partial exon 6, was cloned
into the Not I-Kpn I of cloning site B. Homologous target-
ing would result in complete intron 3, partial exon 3 and
partial exon 4 replacement by the neomycin-resistance
cassette, resulting in the disruption of the ABC Walker A
motif (Figure 1a).
ES cells (129/SvEvTac-cell line) were electroporated with
the linearized targeting vector DNA and cultured on sub-
confluent embryonic fibroblasts. Transfected cell colonies
were selected by culturing cells in medium containing 200
µg/mL G418 (Life Technologies, Rockville, MD, USA).
The ES cells were screened for homologous recombina-
tion by PCR with the forward primer, neoF (5'-
GGGTCGTTTGTTCGGATCAA-3') from neo cassette, and
reverse primer intron 6R (5'-ACCAGTTGGTC-
CTAGCTCGA-3'), which is located outside the targeting
construct in mouse Abcg8 intron 6. Positively targeted ES
cell clones were confirmed by Southern blotting, using ES
cell DNA digested by BamHI and a probe comprising of a
562 bp PCR fragment from partial intron 2 and exon 3 of
Abcg8 gene.
Positively targeted ES cells were microinjected into
C57BL6 blastocysts and transplanted into pseudopreg-
nant recipients. Five highly chimeric mice (agouti coat
color, three males and two females) were isolated and
bred with C57BL/6J mice to generate germ-line transmis-
sion heterozygous mice of Abcg8 gene disruption. Hetero-
zygous offspring mice were back-crossed to C57BL/6J
mice (n > 5) to produce disrupted line and inter-crossed
to generate knockout mice.
Animals and diets
All mice were maintained on a standard rodent chow
(Harlan Teklad mouse/rat diet LM-485) which contained
61 mg/kg cholesterol, 31 mg/kg campesterol, and 105
mg/kg sitosterol, given free access to water and main-
tained at 25°C with a 12-h light, 12-h dark cycle. All ani-
mals were housed in the facilities for laboratory animals
provided by the Division of Laboratory Animal Resources
ACLAM. The Institutional Animal Care and Research
Advisory Committee at Medical University of South Caro-
lina approved all experiments.
Genotyping by PCR
Mouse tail DNA was isolated and purified by cutting
approximately 0.5 cm of mouse tail and digesting it in 500
µl lysis buffer (50 mM Tris-HCl, pH8.0, 100 mM EDTA,
125 mM NaCl, 1% SDS, 200 µg Proteinase K) with rock-
ing overnight at 55°C. 200 µl saturated NaCl was added
into digested solution with vigorous shaking for at least
60 seconds. Mixed solution was spun down at maximum
speed in top micro-centrifuge for 20 min. The supernatant
was transferred to a new tube with equal volume 100%
EtOH and mixed by inversion. The DNA pellet was
washed in 70% EtOH and resuspended in 100–150 µl TE
buffer. UV spectrophotometry and electrophoresis were
used to analyze the quality and quantity of the genomic
DNA. Genotyping was performed by multiplex PCR reac-
tion using three separate primers (two Abcg8 gene specific
primers, mg8-in3F 5'-CCCAATGATGAATGAGACGCT-3',
mg8-R9 5'-TTTGTCACGCTGGGCCTGG-3' and neoF for
identification of Abcg8 target status). The PCR reaction
consisted of 1x PCR buffer (1.5 mM MgCl2, 16 mM
(NH4)2SO4, 0.1 mM dNTPs, 67 mM Tris-HCl (pH8.8)) 1µM of each primer, water and 1.0 units of Taq polymerase.
The reactions were cycled as follows: 94°C for 30 sec,
60°C for 30 sec, 72°C for 1 min for 35 cycles. The PCR
products were identified by electrophoresis.
Southern blot analysis
To confirm PCR results, DNAs were digested with Bam HI,
subjected to electrophoresis in a 0.6% agarose gel and
transferred to nylon membrane. Southern blot filters were
hybridized with a 562 bp PCR fragment from partial
intron 2 and exon 3 of Abcg8 32P-randomly-labeled probe
as previously described [22].
Northern blot analysis
Isolation of liver and intestinal total RNA from Abcg8+/+,
Abcg8+/- and Abcg8-/- mice and Northern blot analyses
were performed as previously described [23]. The probe
for Abcg5 was 1964 bp (nt 136–2099, GeneBank™ acces-
sion no. AH011511) and the probe for Abcg8 was 2019 bp
(nt 103–2126, GeneBank™ accession no. AH011518).
Reverse Transcription (RT)-PCR
To confirm that there was no alternative splicing of the
disrupted allele, RT-PCR was performed on cDNAs of
pooled mouse liver. Briefly, samples of total RNA (0.5 µg)
from pooled mouse livers (n = 4) were reverse transcribed
according to the SuperScript™ First-Strand Synthesis Sys-
tem (Invitrogen, Carlsbad, CA, USA) using random hex-
amers in a final total reaction volume of 20 µl. RT-PCR
was performed using primers located outside of the tar-
geted region: F1 (CCTCAGCTGGTGAGGAGGTG) with R1
(GATGGAGAAGGTGAAGTTGCC), F2 (ATTTCCAAT-
GACTTCCGGGAC) with R1 and F3 (CTGGAAGACG-
GGCTGTACACT) with R1, to produce expected product
lengths of 1449, 654 and 429 bp respectively in wild-type
cDNA.
Quantitative RT-PCR
Primers were based upon previously published primer
sets [24-26] or designed using MacVector, which were
designed from either mRNA or cDNA to avoid the ampli-Page 3 of 21
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Generation of mice deficient in Abcg8/sterolin-2. The targeted disruption strategy of Abcg8 is as shown (panel a). Southern blot 
analysis of BamHI digested mouse genomic DNA, probed with [32P]-randomly labelled probe resulting in a 6.0 kb band for wild 
type, a 2.7 kb band for homozygous and two bands of 5.9 and 2.6 kb for the heterozygote (panel b). Northern blot analysis of 
hepatic RNA showed a loss of Abcg8/sterolin-2 mRNA in the homozygote and decreased Abcg8/sterolin-2 mRNA in the het-
erozygote, although Abcg5/sterolin-1 mRNA appeared relatively unaffected in the knockout mice (panel c). Probes were 
approximately 1.9 kb for Abcg5 and 2 kb for Abcg8 (see Methods for more detail). RT-PCR analyses of hepatic cDNA showed 
no Abcg8/sterolin-2 message, downstream of exon 4 in the Abcg8-/- mice, whether primers were located in exons 4 and 13 
(panel d), exons 9 and 13 or exons 10 and 13 (panel e).
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total RNA sample (Table 1). Samples of total RNA (0.5 µg)
from pooled mouse livers (n = 4) were reverse transcribed
according to the SuperScript™ First-Strand Synthesis Sys-
tem (Invitrogen, Carlsbad, CA, USA) using random hex-
amers with a final total reaction volume of 20 µl.
Quantitative RT-PCR was performed on a PE Biosystems
GeneAmp® 5700 sequence Detection System (Forest City,
CA, USA). Standard reaction volume was 10 µl containing
1 × QuantiTect SYBR Green PCR master mix (Qiagen,
Valencia, CA, USA), 0.002 U AmpErase UNG enzyme (PE
Biosystems, Forest City, CA, USA), 0.7 µl of cDNA tem-
plate from reverse transcription reaction as above and
100–500 nM of oligonucleotide primers. Initial steps of
RT-PCR were two minutes at 50°C for UNG activation,
followed by a 15 minute hold at 95°C. Cycles (n = 40)
consisted of a 15 second melt at 95°C, followed by a 1
minute annealing/extension at 60°C. The final step was a
60°C incubation for 1 minute. At the end of the run, sam-
ples were heated to 95°C with a ramp time of 20 minutes
to construct dissociation curves to ensure that single PCR
products were obtained. All reactions were performed in
triplicate. Threshold cycle (CT) analysis of all samples was
set at 0.5 relative fluorescence units. The relative quanti-
ties of message of genes of interest from the mouse liver
samples used in real-time RT-PCR were normalized to
cyclophilin to compensate for variations in input RNA
amounts. The data were analyzed using the comparative
threshold cycle method (CT). Briefly, the CT values are
averaged, from the triplicates defining a ∆-CT value calcu-
lated by taking the average CT of the gene of interest and
subtracting it from the average CT of cyclophilin. The ∆∆-
CT was calculated by subtracting the average ∆-CT(calibrator)
values from the ∆-CT(sample). The relative quantification
was then calculated by the expression 2-Average∆∆-CT. The
mRNA quantity for the calibrator (wild type) was
expressed as 1 and all other quantities were expressed as a
fold difference relative to the calibrator (wild type).
Plasma lipid analysis by fast protein liquid 
chromatography
Following 16 hrs of fasting, blood samples (n = 3) from
each of the Abcg8+/+, Abcg8+/- and Abcg8-/- mice were col-
lected from the retro-orbital venous plexus using
heparinized capillary tubes under isoflurane anesthesia,
and placed into precooled tubes containing 10 µl of 0.5 M
EDTA. Equal volumes of plasma from each genotype were
pooled and 100 µL of the pooled sample were injected
and fractionated by fast protein liquid chromatography
(FPLC) using a Superose 6 HR10/30 column (Pharmacia
Biotech Inc., Piscataway, NJ, USA) and analyzed as
described [27].
Sterol composition of plasma and tissues
Following a four-hour fast of 12-week-old mice fed on
regular rodent chow diet; blood and tissues were collected
under isofluorane anesthesia from each of the Abcg8+/+,
Abcg8+/- and Abcg8-/- mice (n = 3 for each group). Blood
was collected from the retro-orbital venous plexus by
heparinized glass tube. The animals were sacrificed by cer-
vical dislocation for tissue collection. Plasma (100 µl) was
saponified in 1 N NaOH for one hour, 1.5 mL water
Table 1: Oligonucleotide primers used for quantitative RT-PCR
Target gene Primer sequence Length of amplicon GenBank accession no.
Abcg5 Forward: 5'-AGGTCATGATGCTAGATGAGC-3' 260 bp AH011511
Reverse: 5'-CAAAGGGATTGGAATGTTCAG-3'
Abcg8 Forward: 5'-CTCCTCGGAAAGTGACAACAG-3' 190 bp AH011518
Reverse: 5'-TAGATTTCGGATGCCCAGCTC-3'
Hmgr Forward: 5'-CCGGCAACAACAAGATCTGTG-3' 114 bp BB664708
Reverse: 5'-ATGTACAGGATGGCGATGCA-3'
Cyp7a1 Forward: 5'-CAGGGAGATGCTCTGTGTTCA-3' 121 bp NM_007824
Reverse: 5'-AGGCATACATCCCTTCCGTGA-3'
Abca1 Forward: 5'-CCCAGAGCAAAAAGCGACTC-3' 89 bp NM_013454
Reverse: 5'-GGTCATCATCACTTTGGTCCTTG-3'
Mdr2 (Abcb4) Forward: 5'-GCAGCGAGAAACGGAACAG-3' 64 bp NM_008830
Reverse: 5'-GGTTGCTGATGCTGCCTAGTT-3'
LXRα Forward: 5'-GCTCTGCTCATTGCCATCAG-3' 79 bp AF085745
Reverse: 5'-TGTTGCAGCCTCTCTACTTGGA-3'
Srebp-1c Forward: 5'-GGAGCCATGGATTGCACATT-3' 103 bp BI656094
Reverse: 5'-CCTGTCTCACCCCCAGCATA-3'
Srebp-2 Forward: 5'-CTGCAGCCTCAAGTGCAAAG-3' 119 bp AF374267
Reverse: 5'-CAGTGTGCCATTGGCTGTCT-3'
Cyclophilin Forward: 5'-AAGTTCCATCGTGTCATCAAGGAC-3' 173 bp M60456
Reverse: 5'-CCATTGGTGTCTTTGCCTGC-3'Page 5 of 21
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of 1.5 mL ethyl acetate, containing 70 µg 5α-cholestane as
an internal standard, pooled and dried. Mouse tissues
(liver, spleen and brain) were weighed, homogenized in 1
mL phosphate buffer saline (PBS) with a dounce homog-
enizer (15 strokes at 500 rpm) and a small aliquot of the
whole homogenate assayed for protein concentration.
Aliquots for sterol analysis from whole tissue
homogenates were extracted as described above. Dried
sterol samples were derivatized as trimethylsilylethers,
redissolved in 10 µL hexane and 2 µL samples were
injected into a capillary column (26 m length, 0.32 mm
ID, 0.45 mm OD) coated with liquid CpWAX 57 CB
(Chrompak, Bridgewater, NJ, USA) in a Hewlett-Packard
Gas Chromatograph equipped with a flame ionization
detector [28]. Concentrations of plasma and tissue sterols
were reported as mg/dL and µg/g wet weight tissue,
respectively.
Polyclonal antibody production
Three separate polyclonal anti-Abcg5/sterolin-1 antibod-
ies have been raised as previously described [20,29,30]. In
experiments, anti-Abcg5/sterolin-1 antibodies are
labelled as follows:
1) SC – from the Patel group, 2) AMC – from the AMC
Liver Center group, and 3) UTSW – from the Hobbs
group.
Membrane protein preparations
Total membranes were prepared by taking approximately
500 mg of liver tissue cut into small pieces and homoge-
nized in ice cold lysis buffer (5 mM Tris-pH7.5, 250 mM
sucrose with protease inhibitors) by a dounce homoge-
nizer times 10 strokes. Samples were then subjected to
centrifugation – 1300 g for 10 minutes at 4°C. The super-
nant was saved and the pellet was resuspended and again
subjected to dounce homogenization times 10 strokes
then centrifuged 1000 g for 10 minutes at 4°C. This step
was repeated twice each time with the supernant being
collected and kept on ice. The supernants were then
pooled and subjected to ultracentrifugation at 100,000 g
for 60 minutes at 4°C. The supernant was removed and
the pellet was resuspended in lysis buffer. Plasma mem-
branes were prepared as previously described [31]. Pro-
tein sample concentrations were then determined by Bio-
Rad protein colormetric assay per manufacturer's protocol
(BioRad, Hercules, CA, USA). 50 µg of membrane pro-
teins were then resolved on 7.5% SDS acrylamide gel.
Immunoblotting
Proteins resolved by SDS-PAGE were transferred to nitro-
cellulose membranes. Membranes were then blocked for
one hour in 5% dry milk in PBS-T (Phosphate Buffered
saline and 0.1% Tween 20). Blots were then probed with
primary antibody against Abcg5 in 5% milk in PBS-T over-
night at 4°C. The blot was then washed three times for
five minutes in TBS-T (Tris Buffered Saline/0.1% Tween-
20) with 150 mM NaCl, and secondarily stained with
goat-anti-rabbit conjugated HRP 1:10,000 dilution in 5%
milk in PBS-T for one hour. The blot was again washed
three times for five minutes in TBS-T with 150 mM NaCl
then covered in Western Lightning® Chemiluminescence
Reagent Plus (PerkinElmer Life Sciences, Inc. Boston, MA,
USA), wrapped in plastic, exposed to film and developed.
Immunohistochemical analysis
Snap-frozen liver and intestine tissue were cut to produce
8 µm thick frozen sections, air-dried for 30 minutes onto
glass slides and stored at -80°C until required. The slides
were stained with hematoxylin, rinsed three times with
PBS, fixed for 10 min with cooled methanol at -20°C and
then rinsed three times with PBS. Slides for antibody
staining were initially blocked in PBS/0.1 M glycine/10%
goat serum for 60 min at room temperature then incu-
bated with anti-sterolin-1 antibody (1:15 dilution) over-
night at 4°C. The slides were washed with 1 × PBS and
incubated with secondary antibody (goat-anti-rabbit IgG
conjugated with rhodamine, 1:1000 dilution) for 30 min
at room temperature, washed and then observed under an
Olympus BX-5 confocal microscope with Fluoview. The
sections stained at the AMC Liver Center were fixed in
100% acetone for 30 min at room temperature, blocked
in a solution of PBS/0.05% Tween-20/5% goat serum
(GS) for one hour, then incubated with Anti-sterolin-1
(1:40 dilution) and anti-Bsep (1:200 dilution) diluted in
PBS/Tween/GS, for one hour. Thereafter, slides were
washed 3 × 10 min in PBS/Tween and the secondary anti-
body (goat-anti-rabbit Alexa 488) was applied in 1:1000
dilution in PBST/GS for one hour at room temperature.
After washing for 3 × 10 min the sections were mounted
in Dapi/Dapco solution. Fluorescence microscopy was
done with a Leica DM RA2 microscope equipped with a
Leica DC350F photo camera. For Dapi staining, 359 nm
(30.38 ms exposure) was used and for Abcg5 and Bsep
staining, 514 nm (for both: 1654.34 ms exposure) was
used and the pictures were analyzed and overlaid using
FW4000 software (Leica).
Transfection and immunostaining of COS-1 cells
COS-1 cells were transiently transfected with pCMV-
mouse Abcg5 and pCMV-mouse Abcg8 expression con-
structs using the Qiagen SuperFect reagent per protocol
(Valencia, CA, USA). Briefly, COS-1 cells were seeded
onto a six-well plate the day prior to transfection to gener-
ate 60% confluence when grown at 37°C and 5% CO2 in
DMEM supplemented with 10% FBS, 100 U/ml penicil-
lin, 100 µg/ml streptomycin and 1 × glutamine. On the
day of transfection, 2 µg of DNA was mixed with Qiagen
SuperFect reagent and incubated for 10 minutes. This mix-Page 6 of 21
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the cells to incubate for two hours. The cells were washed
once with 1x PBS and fresh media was added. The trans-
fected cells were then incubated for 48 hours to ensure
expression and subsequently fixed with a 1:1 mixture of
acetone:methanol. In preparation for immunostaining,
cells were blocked with 2% goat serum in PBS for 30 min-
utes, then incubated with 1:50 dilution of primary anti-
body anti-Abcg5 in 2% goat serum-PBS for 1.5 hours, and
subsequently incubated with secondary rhodamine anti-
rabbit IgG antibody for 30 minutes. Cells were then
observed under an Olympus BX-5 confocal microscope
with Fluoview.
Dynamic biliary lipid collection and analysis
Mice were anaesthetized by intraperitoneal injection of 1
mL/kg fentanyl/fluanisone and 10 mg/kg Diazepam. The
abdomen was opened and, after distal ligation of the bile
duct, the gallbladder was cannulated. Bile sampling
started directly after cannulation and was collected for 10
min. Bile flow was determined gravimetrically. Biliary bile
salt, sterol and phospholipid concentrations were deter-
mined as described previously [32]. To determine maxi-
mal secretion rates of biliary lipid secretion, bile was
diverted for 90 min to deplete the endogenous bile salt
pool. Subsequently, tauroursodeoxycholate (Sigma
Chemical Co., MO, USA) dissolved in PBS was infused
into the jugular vein in stepwise increasing rates from
600–1,800 nmol/min/100 g body weight. Bile was col-
lected in 10 min fractions and analyzed for bile salt and
lipid content. In separate experiments, following distal
ligation of the bile duct and cannulation of gallbladder,
bile was diverted for 30 minutes while mice were infused
with sterile PBS. Subsequently, the mice were infused con-
tinuously with 1,200 nmol/min/100 g body weight of
tauroursodeoxycholate and two 30-minute fractions were
collected. Sterol analyses of bile was performed by GC
analysis as described above.
Assay of HMG-CoA and cholesterol 7α-hydroxylase 
enzyme activity
Mouse liver microsomes were prepared by differential
centrifugation [33]. Briefly, 0.1–0.2 g liver was homoge-
nized in a Potter-Elvjhem homogenizer with five volumes
of buffer (0.25 M sucrose, 0.1 M Tris, 0.1 mM disodium
EDTA, 0.1 mM DTT, pH 7.4). Microsomes were isolated
by differential centrifugation (10,000 g to 100,000 g). The
pellets were washed and resuspended in storage buffer
(0.1 M dipotassium phosphate, 0.05 M KCl, 1 mM DTT, 5
mM disodium EDTA, 20% glycerol, pH 7.4) at 25–30 mg
protein/ml. Protein concentrations were determined
according to the method of Lowry et al. [34]. The activity
of cholesterol 7α-hydroxylase (EC 1.14.12.17) was meas-
ured by an isotope incorporation method according to
Shefer et al. [33] with some modifications. The reaction
mixture (final volume 0.5 ml) consisted of potassium
phosphate buffer (100 mM K2HPO4, 0.1 mM EDTA, 5
mM DTT, 30 mM nicotinamide, pH 7.4), [14C]-choles-
terol (5 × 105 dpm) solubilized in 50 µl of 25% (wt/vol)
β-cyclodextrin (final concentration 0.8%), and 50–200 µg
of microsomal protein. The reaction was initiated by the
addition of NADPH or an NADPH-generating system (3.4
mM NADP+, 30 mM glucose-6-phosphate, 0.3 U of glu-
cose-6-phosphate dehydrogenase) and continued for 15
min at 37°C. The reaction was stopped with 0.5 ml of 1 N
KOH, 5 µg of butylated hydroxytoluene, and 10 µl of eth-
anolic potassium hydroxide. [3H] 7α-hydroxycholesterol
(1 × 104 dpm/5 µg) was added as an internal recovery
standard. After saponification at 37°C for one hour, ster-
ols were extracted twice with 3 ml of n-hexane and the
extracts were evaporated to dryness under nitrogen. The
residue was dissolved in 0.3 ml of n-hexane:2-propanol
(97.3 vol/vol) and applied to a silica column (500 mg;
sep-pak, by 4 ml of n-hexane:2-propanol (97.3 vol/vol)).
7α-hydroxycholesterol was eluted with 3 ml of n-hex-
ane:2-propanol (80:20 vol:vol) and further isolated by
TLC on silica gel plates (Silica gel 60, EM Science, Gibbes-
town, NJ, USA) with diethyl ether, and quantified by liq-
uid scintillation counting using Ecolume (ICN
Radiochemicals Irvine, CA, USA). Assays were carried out
in duplicate with correction for zero-time controls. HMG-
CoA reductase (EC 1.1.1.3.4) activity was determined
according to the method of Xu et al. [35] with modifica-
tions as described [36].
Statistical analysis
Data are shown as means ± SD. The Student's t test was
used to determine the statistical significance of differences
between the groups of animals. Significance was set at P
values <0.05.
Results
Isolation of Abcg8/sterolin-2 deficient mice
The targeting construct (Figure 1a) results in the potential
disruption of normal splicing, as well as loss of some cod-
ing sequences involving exons 3 and 4. After ES cell elec-
troporation with the linearized targeted plasmid DNA,
two homologous recombinant ES clones (out of 58 ES
clones screened) were identified. Blastocyst injection of
these resulted in five highly chimeric mice (three males,
two females). One male and one female, both from the
same ES clone, showed germline transmission and the
female line was used to establish a multi-generational col-
ony bred onto a C57Bl/6J background.
Heterozygous mice were fertile and gave rise to normal lit-
ter sizes. Breeding heterozygous animals led to wild-type,
heterozygous and homozygous knockout mice in the
expected Mendelian distribution (data not shown).
Although not quantitative, Northern analyses showedPage 7 of 21
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mRNA for Abcg8, expression of Abcg5 appeared unaltered
(Figure 1c). To exclude the possibility of alternative splic-
ing with the production of a non-functional but truncated
Abcg8/sterolin-2 protein that may serve as a chaperone for
Abcg5/sterolin-1, RT-PCR was performed on cDNA
reverse transcribed from total liver RNA from Abcg8-defi-
cient mice. No mRNA for Abcg8/sterolin-2 was detected
containing any sequences downstream of exon 4 in the
Abcg8-deficient mice, whether primers were located in
exons 4 and 13, exons 9 and 13 or exons 10 and 13 (Figure
1d,1e). This demonstrates that if an alternatively spliced
message could potentially code for a truncated protein, it
is not detectable in the Abcg8-deficient mice. The mem-
brane-spanning domains of Abcg8/sterolin-2 are encoded
by exons 9–13.
Sterol levels in Abcg8/sterolin-2 deficient animals
Elevated plant sterols in tissue and plasma are diagnostic
of sitosterolemia. Sterol levels, as determined by gas chro-
matography (GC) analysis, in plasma and tissues of the
Abcg8-/- mice are shown in Table 2. There were no differ-
ences in tissue weights between wild types, heterozygotes
and knockouts. Plasma cholesterol levels of the
homozygous and heterozygous mice were decreased by
52% and 26%, respectively, compared to those of wild-
type mice (n = 3 all groups, Table 2). Plant sterols were
almost undetectable in wild-type and heterozygous mice,
but were significantly elevated in Abcg8-/- mice. Plasma
campesterol and sitosterol levels were eight- and 36-fold
higher in Abcg8-/- mice compared to wild-type mice (8.76
± 2.10 and 18.52 ± 5.03 mg/dL, respectively, versus 1.14 ±
0.69 and 0.50 ± 0.55 mg/dL). There was no significant dif-
ference in the plasma plant sterol levels between hetero-
zygous and wild-type mice. Liver cholesterol content of
the Abcg8-/- mice was reduced by ~50% relative to wild-
type liver (1202 ± 264 µg/g wet weight tissue, versus 2280
± 310 µg/g wet weight tissue, respectively). The reduced
cholesterol content was offset by a five-fold increase in
campesterol and a 22-fold increase in sitosterol (233.9 ±
48.1 and 376.3 ± 96.1 µg/g wet weight tissue, respectively)
in Abcg8-/- knockout mice compared to wild-type mice
(52.2 ± 15.0 and 16.7 ± 8.6 µg/g wet weight tissue, respec-
tively, Table 2). There were no significant differences of
Table 2: Mouse plasma and tissue sterol analyses
Plasma (mg/dL)
Group Cholesterol Campesterol Stigmasterol β-Sitosterol
Abcg8+/+ 73.0 ± 14 1.1 ± 0.7 ND 0.5 ± 0.5
Abcg8+/- 54.0 ± 10* 1.8 ± 0.3* ND 0.8 ± 0.2*
Abcg8-/- 35.0 ± 6.0* 8.8 ± 2.1* ND 18.5 ± 5.0*
Liver (µg/g wet tissue)
Group Cholesterol Campesterol Stigmasterol β-Sitosterol
Abcg8+/+ 2280 ± 310 52.2 ± 15.0 ND 16.7 ± 8.6
Abcg8+/- 2460 ± 588 76.4 ± 12.3* 1.6 ± 3.3* 26.7 ± 6.4*
Abcg8-/- 1202 ± 264* 233.9 ± 48.1* 22.7 ± 6.3* 376.3 ± 91.6*
Spleen (µg/g wet tissue)
Group Cholesterol Campesterol Stigmasterol β-Sitosterol
Abcg8+/+ 2702 ± 310 41.7 ± 7.6 15.1 ± 14.1 21.9 ± 10.9
Abcg8+/- 2578 ± 320 66.8 ± 18.8* 14.5 ± 16.9* 32.2 ± 6.1*
Abcg8-/- 1779 ± 195* 353.8 ± 97.5* ND* 436.6 ± 148.5*
Brain (µg/g wet tissue)
Group Cholesterol Plant sterols Desmosterol Lathosterol
Abcg8+/+ 11301 ± 156 10.2 ± 3.9 102.0 ± 13.3 52.0 ± 0.3
Abcg8+/- 11846 ± 814 24.5 ± 5.5 113.7 ± 25.5 49.1 ± 4.2
Abcg8-/- 11846 ± 1061 63.0 ± 6.5 123 ± 18.3 56.9 ± 9.5
Animals used in these studies were 12 weeks of age, a mixture of male and female and fed a regular chow diet. *P < 0.05 for -/- versus +/+ and -/- 
versus +/-. ND, not detectable.Page 8 of 21
(page number not for citation purposes)
BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5liver cholesterol or plant sterol contents between Abcg8+/
+ and Abcg8+/- mice. Spleen sterol contents reflected the
liver profiles (Table 2). No significant differences in brain
sterol contents were observed, as would be expected, since
the blood brain barrier is intact and prevents entry of
these sterols in sitosterolemia (Table 2). There were only
traces of plant sterols in the brains from knockout ani-
mals, reflecting blood contamination during tissue
harvesting.
Interestingly, the majority of the elevated tissue plant ster-
ols are unesterified. The livers of Abcg8+/+, +/- and -/-
mice have relatively similar levels of esterified cholesterol
(Figure 2a). However, there is little if any esterification of
sitosterol or campesterol (Figure 2b,2c) consistent with
previous findings [37,38]. Thus all of the expansion of tis-
sue sterol pools are as free sterols.
FPLC analyses for sterols (measured enzymatically and
thus reflecting total sterols) and triglycerides were per-
formed on plasma samples from fasted animals fed a reg-
ular chow diet. No significant differences were observed
for the sterol profiles (Figure 3a), but surprisingly, the
Abcg8-/- knockout mice had a significantly higher triglyc-
eride level in the LDL lipoprotein fractions compared to
wild-type and heterozygous mice (Figure 3b). The size of
this peak was variable between different littermate analy-
ses, but is always increased in the knockout animals. Total
plasma triglyceride levels of the Abcg8-/- mice were
slightly higher (79.2 ± 14 mg/dL compared to the wild
type 63.4 ± 13 mg/dL and heterozygotes 46.6 ± 12 mg/dL,
n = 3 for all genotypes). Preliminary analyses of proteins
in the isolated FPLC fractions did not show any qualita-
tive changes in apolipoproteins B, E, AI, or AII. The signif-
icance of this triglyceride rich peak remains unclear at
present.
Liver gene expression and enzyme activity change in 
Abcg8/sterolin-2 deficient mice
To investigate the effects of a deficiency of Abcg8/sterolin-
2 on the genes that regulate sterol metabolism, quantita-
tive RT-PCR was performed looking at the expression lev-
els of Abcg5, Abcg8, Hmgr, Cyp7a1, Abca1, Mdr2, Lxr, Srebp-
1c, and Srebp-2 mRNA in the livers of mice fed a regular
chow diet (Figure 4a). As expected, Abcg8 mRNA expres-
sion levels were undetectable in the Abcg8-/- mice and
were reduced by ~50% in the heterozygous mice, relative
to wild-type mice. Interestingly, by quantitative RT-PCR,
the mRNA expression of Abcg5 in the knock-out mice was
also reduced by more than 60% compared to the wild-
type mice, although no changes were noted in the hetero-
zygous mice. Expression of HMG-CoA reductase mRNA
was decreased by ~50% and ~80% in the heterozygote
and knockout mice respectively, in keeping with limited
observations in human patients with this disorder [7].
To verify whether the mRNA changes resulted in altera-
tion of the enzyme activity changes, liver samples were
analyzed for HMG-CoA reductase activity and Cyp7a1
activity (Figure 4b). HMG-CoA reductase activity was
reduced by 30% and 60% in the Abcg8+/- and Abcg8-/-
mice, respectively (Figure 4b), and thus reflected the
changes in mRNA expression. In contrast, although the
Cyp7a1 mRNA expression levels were essentially
unchanged in the knockout mouse, Cyp7a1 activity was
significantly decreased by 37% (P < 0.01). In the hetero-
zygous mice, both the mRNA and activity of Cyp7a1 were
decreased. Sitosterol is known to be a direct competitive
inhibitor of Cyp7a1 and it is likely that the elevated plant
sterols in the liver are responsible for the inhibition in the
knockout mouse [39].
Localization of Abcg5 protein in Abcg8-/- knockout mice
Does the loss of Abcg8/sterolin-2 result in loss of Abcg5/
sterolin-1 expression, as might be predicted from the
genetic studies and more recently from the in vitro and in
vivo expression studies? A robust antibody to mouse
Abcg8/sterolin-2 is not currently available. However,
three separate groups have developed rabbit polyclonal
antibody to mouse Abcg5/sterolin-1. These three antibod-
ies were used in Western blotting and immunohistochem-
istry experiments on the liver and intestine of Abcg8-/-
mice. Western blotting of liver total membrane prepara-
tions using the three separately-developed anti-Abcg5/
sterolin-1 antibodies showed different results. As has been
previously published, Abcg5/sterolin-1 exists in two sepa-
rate forms, the 'immature' 75 kDa protein and a fully gly-
cosylated 'mature' 93 kDa protein [18,30]. Using the SC
anti-Abcg5/sterolin-1 peptide antibody, a 75 kDa band is
detected (Figure 5a). This antibody does not detect a
'mature' 93 kDa band in either wild-type or knockout ani-
mals nor is the 75 kDa band sensitive to either Endo-H or
PNGaseF (lower panel shows same aliquots probed with
anti-transferrin). The AMC antibody detects the 'mature'
form of Abcg5/sterolin-1 in wild-type animals but not the
knockouts. Interestingly, the 'immature' 75 kDa band is
detected by this antibody but the band shifts with Endo-
H and PNGase F treatment (Figure 5b). The UTSW anti-
body detects the 'mature' and 'immature' forms of Abcg5/
sterolin-1 in wild-type animals but detects no forms in the
knockout mouse (Figure 5c). What does hold true for all
antibodies used against Abcg5/sterolin-1 is the detection
of a 75 kDa band.
Immunohistochemistry experiments were carried out
using all three antibodies. In acute transfection studies,
the SC antibody recognized over-expressed mouse Abcg5/
sterolin-1 in COS-1 cells, but not mouse Abcg8/sterolin-2
(Figure 6b,6c). Co-transfection of COS-1 cells with both
Abcg5 and Abcg8 cDNAs did not alter the pattern of
immunofluorescence, although we are not able to con-Page 9 of 21
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5Free versus esterified sterol levels in the livers of Abcg8+/+, Abcg8+/- and Abcg8-/- miceigur  2
Free versus esterified sterol levels in the livers of Abcg8+/+, Abcg8+/- and Abcg8-/- mice. Sterol contents of liver extracts of 12-
week-old female mice fed a regular chow diet, determined by GC analysis show that the majority of sterols in all genotypes are 
unesterified. Esterified cholesterol (panel a) remains relatively constant for each genotype. However, no esterified sitosterol in 
the livers from Abcg8+/+ and Abcg8+/- mice and very little from Abcg8-/- mice was detected (panel b). Small amounts of esteri-
fied campesterol were detected in each of the genotypes (panel c).
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5firm simultaneous expression of Abcg8 in cells expressing
Abcg5/sterolin-1, as we have no suitable antibody for
Abcg8/sterolin-2 (Figure 6d). Nevertheless, this experi-
ment indicates that the SC antibody can recognize Abcg5/
sterolin-1 but does not cross-react with Abcg8/sterolin-2.
Serial sections of intestinal tissue were incubated with
anti-Abcg5/sterolin-1 to determine the cellular location of
Abcg5/sterolin-1. The pattern of staining of Abcg5/stero-
lin-1 in the intestinal sections is clearly apical and local-
ized to the villi of the enterocytes (Figure 6g,6h,6i). Loss
of Abcg8/sterolin-2 does not seem to affect this pattern of
staining. To further confirm that the antibody used recog-
nizes Abcg5/sterolin-1; this pattern is blocked if the anti-
body is pre-incubated with the peptide to which it was
raised (Figure 6f). To further confirm that Abcg5/sterolin-
1 expression is preserved and may be apical, immunohis-
tochemistry was performed in Amsterdam using the AMC
antibody to stain liver sections from wild-type and knock-
out mice [30]. As a control, the expression of Abcb11, an
ABC transporter known to be responsible for the export of
bile salts, was compared to that of Abcg5/sterolin-1 (Fig-
ure 6j,6k). Again, both proteins are apically localized in
liver sections from wild-type mice and this pattern is
essentially unperturbed in liver from knockout mice,
although the expression level of Abcg5/sterolin-1 seems to
be less robust qualitatively (Figure 6l,6m). To further con-
firm the apical expression of Abcg5/sterolin-1 in the
knockout mice, the UTSW antibody was used to stain liver
sections of wild-type and knockout mice. Again, there is
apical expression of Abcg5/sterolin-1 in both wild-type
and knockout livers (Figure 7a,7b).
Biliary secretion of bile salts, sterol and phospholipids in 
Abcg8/sterolin-2 deficient mice
Sitosterolemic individuals have an impaired ability to
secrete cholesterol and plant sterols into bile [40,41]. We
analyzed the knockout mice for any alterations in biliary
sterol handling. Analyses of the initial basal bile secretion
showed that the sterol and phospholipid contents in
Abcg8-/- mice were reduced as compared to wild-type
mice, (Figure 8a,8b,8c, bile salt secretion not statistically
significant, for sterol secretion P = 0.01 and for phosphol-
ipid secretion P = 0.03).
To investigate whether the defect in biliary sterol secretion
could be (partly) restored by forced biliary sterol
secretion, we infused mice with stepwise increasing doses
of tauroursodeoxycholic acid (TUDC). Mice were first
depleted of their endogenous bile salt pools for 90 min
and subsequently infused via the jugular vein with
increasing doses of TUDC. As shown in Figure 8d, bile salt
secretion was no different between the different genotypes
during the depletion or the TUDC infusion phases of the
experiment. However, a different pattern emerged for the
secretion of phospholipid (Figure 8f). There was no differ-
ence between wild-type and heterozygous mice, but
knockout mice showed a trend of lower phospholipid
secretion during both the depletion and infusion phase.
Even more dramatic was the effect on biliary sterol secre-
Lipid profiles of the plasma of Abcg8+/+, Abcg8+/- and Abcg8-/- miceFigure 3
Lipid profiles of the plasma of Abcg8+/+, Abcg8+/- and Abcg8-/- mice. Lipoproteins were separated from pooled mouse plasma 
samples by FPLC. Total sterols (panel a) and triglyceride (panel b) profiles of the fractions are shown. There was no difference 
of cholesterol profiles in the groups, but there was a small triglyceride peak in Abcg8-/- mice in fractions 21–25, corresponding 
to the LDL-size range, the significance of which is not known at present.
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5Analyses of mRNA expression and enzyme activity in mouse liversFigure 4
Analyses of mRNA expression and enzyme activity in mouse livers. Panel (a) shows RT-PCR quantitation of mRNA levels for 
Abcg5, Abcg8, Hmgr, Cyp7a1, Abca1, Mdr2, Lxr, Srebp-1c and Srebp-2 in mouse livers from Abcg8+/+ (open bars), Abcg8+/- 
(hatched bars) and Abcg8-/- (filled bars). Knockout mice showed an ~60% reduction in mRNA for Abcg5/sterolin-1 and an 80% 
reduction in the message for HMG CoA reductase. Relatively no message for Abcg8/sterolin-2 was detected in the knockout 
mice. Panel (b) shows the enzyme activities for HMG-CoA reductase and CYP7a1 in livers from Abcg8+/+, Abcg8+/- and Abcg8-
/- mice. Activities of HMG-CoA reductase and CYP7a1 were significantly reduced in the Abcg8-/- mouse liver (*P < 0.05, see 
text for discussion).
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5N-glycosylation of Abcg5/sterolin-1 analyses in Abcg8-/- mouse liverFigure 5
N-glycosylation of Abcg5/sterolin-1 analyses in Abcg8-/- mouse liver. Mouse liver homogenate stained with SC anti-Abcg5/
sterolin-1 after treatment with Endo-H or PNGaseF shows a 75 kDa band present in both genotypes, which is resistant to 
deglycosylation (panel a). Staining of wild-type liver homogenate with preimmune serum showed no detectable bands. Lower 
portion of panel (a) shows the same aliquots stained for anti-transferrin as a control for deglycosylation. AMC anti-Abcg5/
sterolin-1 staining of mouse liver homogenate shows a 'mature' ~90 kDa band in the wild-type mice but not in the Abcg8-/- 
mice (panel b). A 75 kDa form is present which is sensitive to deglycosylation. Mouse liver homogenate stained with UTSW 
anti-Abcg5/sterolin-1 shows a 'mature' ~90 kDa band and an 'immature' 75 kDa band in the wild-type mice but no signal is 
detected in the Abcg8-/- mice. Treatment with Endo-H or PNGaseF results in a lower molecular weight protein in the wild-
type mice. Abcg5/Abcg8-/- liver homogenate used for negative control.
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5Immunohistochemical evaluation of mouse Abcg5/sterolin-1 expression in liver and intestineFigure 6
Immunohistochemical evaluation of mouse Abcg5/sterolin-1 expression in liver and intestine. COS-1 cells were transiently 
transfected with pCMV-mouse Abcg5 or pCMV-mouse Abcg8 constructs, allowed to express for 48 hours then fixed and incu-
bated with antibody. pCMV empty vector transfected COS-1 cells incubated with SC anti-Abcg5/sterolin-1 showed no signifi-
cant fluorescence (panel a). Abcg5 transfected COS-1 cells incubated with SC anti-Abcg5/sterolin-1 antibody showed a 
membrane distribution (panel b), where as Abcg8 transfected cells incubated with SC anti-Abcg5 antibody showed no signifi-
cant fluorescence (panel c). Abcg5 and Abcg8 co-transfected COS-1 cells incubated with SC anti-Abcg5/sterolin-1 antibody 
resulted in a fluorescence pattern similar to Abcg5 alone (panel d). The yellow bar represents 20 µm. Wild-type intestine incu-
bated with SC pre-immune serum (panel e), or SC anti-Abcg5/sterolin-1 antibody pre-incubated with the blocking peptide 
(panel f) showed no specific signals. Wild-type, Abcg8+/- and Abcg8-/- intestine (panels g, h and i respectively) incubated with SC 
anti-Abcg5/sterolin-1 antibody, showed no difference in expression patterns, despite the loss of Abcg8/sterolin-2 in the knock-
out mice. Single arrowhead shows intestinal villus and double arrowhead shows crypt. The yellow bar represents 50 µm. Anti-
body staining of liver sections was also performed at the AMC Liver Center. As a control, an antibody to Bsep/Abcb11 was 
used and showed a clear apical distribution in both wild-type (panel j) and Abcg8 knockout mice (panel k). Using AMC antibody 
against Abcg5/sterolin-1 (see text), in both wild-type (panel l) and Abcg8 knockout liver (panel m), the pattern of expression 
was also apical and unchanged although the signal is fainter compared to that for Bsep/Abcb11 (see text for discussion). 
Arrows indicate bile canaliculi.
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5tion although the sterol contents were determined enzy-
matically and no distinction is made as to whether this is
sitosterol or cholesterol (Figure 8e, but see below). In the
knockout mice, almost no stimulated sterol secretion was
noted, with an intermediate phenotype in the hetero-
zygous mice. In the heterozygous mice, sterol secretion
increased to reach a maximal level of about 50% of the
wild type suggesting that Abcg8/sterolin-2 is a rate-limit-
ing step for biliary 'cholesterol' secretion. In the knockout
mice, sterol secretion remained at a constant level during
the depletion phase and increased minimally upon infu-
sion of TUDC.
Since the Abcg8-/- mice still secreted some sterols we were
interested in which biliary sterol species were being
secreted. Therefore bile was collected from mice during a
constant infusion of TUDC and analyzed by GC. Mice
were first depleted of their endogenous bile acid pools for
30 minutes then infused with a continuous dose of TUDC
(1,200 nmol/min/100 g body weight). The knockout
mice showed a significantly diminished ability to secrete
cholesterol, yet still maintained the ability to secrete sito-
sterol and campesterol compared to wild-type mice (Fig-
ure 9). Surprisingly, the Abcg8+/- mice tended to show an
increased ability to secrete all sterols above the levels seen
in the wild-type mice, although this was not statistically
significant.
Immunohistochemical evaluation of mouse Abcg5/sterolin-1 expression in liverFigure 7
Immunohistochemical evaluation of mouse Abcg5/sterolin-1 expression in liver. Wild-type liver incubated with UTSW anti-
Abcg5/sterolin-1 resulted in apical expression (panel a). Merged image clearly shows the apical distribution. Likewise Abcg8-/- 
liver incubated with the same UTSW anti-Abcg5/sterolin-1 antibody resulted in a similar apical expression pattern relative to 
the wild type (panel b). White arrows indicate bile canaliculi and asterisk indicates a bile duct. The yellow bar represents 50 
µm.
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The mechanism by which dietary cholesterol is specifi-
cally absorbed and dietary non-cholesterol sterols prima-
rily excluded or the mechanism(s) by which the liver can
selectively secrete sterols has not been elucidated. Identi-
fication of the genetic defect(s) in a rare human disorder,
sitosterolemia, where these processes are specifically dis-
rupted, may finally have led to the identification of the
'transporters' responsible for these processes. Complete
defects in one of two genes (but not both), organized in a
head-to-head configuration at the STSL locus, causes sito-
sterolemia. We report a mouse model of sitosterolemia,
with a selective, but complete, defect in one of these
genes, Abcg8. This mouse reflects the known defects
described in human sitosterolemia [5,7,42]. Plasma and
all tissues, apart from the brain, have significantly
elevated sitosterol levels. Homozygous knockout mice are
viable, fertile and sitosterolemic. However, fertility seems
to be reduced when homozygous mice are bred together
(S Patel and J Oatis, unpublished observation).
This model reflects many other observed changes
described in limited studies in humans. For example, in
humans, the activity of HMG-CoA reductase and CYP7a1
have been reported to be low [7,39]. In this study, we
show that the mRNA and enzyme activities in the livers
from knockout animals are also significantly reduced.
Additionally, the activity of the rate-limiting enzyme for
bile acid synthesis, CYP7a1, is reduced, although no
changes at the mRNA level are noted. This is also in keep-
ing with previous studies that show that sitosterol is a
direct inhibitor of this enzyme in vitro [39].
Biliary sterol, phospholipid and bile salt analysesF gure 8
Biliary sterol, phospholipid and bile salt analyses. Bile salt, sterol and phospholipid contents from male Abcg8+/+ (n = 8), 
Abcg8+/- (n = 7), and Abcg8-/- (n = 5) mice were examined as described in Methods. Bile salt secretion following a 10 minute 
collection was lower in Abcg8+/- and Abcg8-/- mice compared to wild type (panel a), but these differences were not statistically 
significant. Biliary sterol and phospholipid were significantly reduced in the Abcg8-/- mice compared to the wild-type (panels b 
and c). *P < 0.05. The lower panel shows biliary bile salt, sterol and phospholipid secretion rates from female Abcg8+/+ (n = 5), 
Abcg8+/- (n = 4), and Abcg8-/- (n = 3) mice measured following 90-minute bile salt depletion followed by stepwise TUDC infu-
sion as described in the text. Bars represent phase TUDC infusion rates. No differences were observed in the ability of the 
Abcg8-/- mice to secrete bile salts (panel d), but there is a marked inability of the knockout mice to secrete sterols (panel e) 
and a trend towards a reduced ability to secrete phospholipid (panel f) compared to wild type.
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Biliary cholesterol and sitosterol secretion. Biliary sterols were analyzed by GC analyses in Abcg8+/+ (n = 4), Abcg8+/- (n = 3) 
and Abcg8-/- (n = 4) mice following 30-minute bile salt depletion followed by a continuous TUDC infusion as described in 
Methods. Abcg8-/- mice were unable to secrete cholesterol into bile with forced TUDC administration relative to the wild-type 
mice (panel a, *P < 0.05). Interestingly, the Abcg8-/- mice were able to still secrete sitosterol (panel b) and campesterol (panel 
c). Heterozygous mice showed an increased ability to secrete all sterols with forced TUDC administration, although the results 
were not statistically significant.
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BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/5Biliary sterols of Abcg8-deficient mice were dramatically
different compared to wild-type mice. Measurement of
biliary sterol secretion rates in Abcg8-/- mice demon-
strated a failure to increase sterol secretion into bile
despite exogenous infusion of bile acids. Furthermore,
complete loss of Abcg8/sterolin-2 results in an inability to
secrete cholesterol into bile, although secretion of
sitosterol seemed to be preserved. Arguably, since the
body pools and plasma sitosterol levels in the knockout
mice are so considerably elevated, perhaps the biliary sito-
sterol levels could be considered to be inappropriately
low. Despite this reservation, the finding that sitosterol is
present in the bile suggests that plant sterols may be
secreted independent of Abcg8/sterolin-2. The ability of
Abcg8-/- mice to secrete bile salt and phospholipid into
bile as compared to wild-type mice was not significantly
impaired. Collectively these data suggest that Abcg8/stero-
lin-2 is necessary for hepatobiliary cholesterol secretion in
mice.
Abcg8-/- mice appeared normal and healthy maintained
on a regular rodent chow diet. Their phenotypic features
are very similar to those recently reported for a mouse
deficient in both sterolins simultaneously [7,20]. Plasma
and hepatic plant sterol levels in Abcg8-/- and Abcg5/Abcg8
knockout are increased similarly with marked decreases in
cholesterol levels. Interestingly, plasma triglyceride levels
of the Abcg8-/- mice were slightly higher than wild-type
animals and this increased triglyceride is carried in the
LDL fraction range, as measured by FPLC. The significance
of this is not clear, although preliminary SDS-PAGE anal-
yses of all the fractions failed to reveal any differences
between wild-type and knockout samples.
Hepatic levels of GC-measured cholesterol were greatly
reduced in Abcg8-/- mice compared to wild-type mice, yet
mRNA levels of HMG-CoA reductase and enzyme activity
are also reduced without any significant change in mRNA
of the Srebps. The basis for this is not clear at present,
unless the increase in non-plant sterols leads to a suppres-
sion of SREBP activation. Sitosterol has been shown to
directly inhibit Cyp7a1 activity in vitro and we presume
this may account for the reduced enzyme activity [39]. In
preliminary studies, when knockout mice are placed on a
low sitosterol diet, the activity of this enzyme, as well as
the mRNA levels are increased (E Klett and S Patel, unpub-
lished observations). Another prediction, based upon the
enzyme and mRNA levels in knockout mice, is that if
these mice are placed on a high cholesterol/high sitosterol
diet, they may show significant accumulation of both ster-
ols in the body. This may also be relevant to the human
disorder where some, although not all affected individu-
als, manifest premature coronary artery disease.
Abcg8/sterolin-2 deficient mice also allow us to examine
the role of this protein in biliary sterol secretion. The bile
is sterol poor and upon stimulation by increasing bile salt
excretion, Abcg8/sterolin-2 deficient mice cannot
respond, in contrast to the wild-type mice. Thus, Abcg8/
sterolin-2 is necessary for cholesterol secretion but not
necessary for plant sterol secretion. It could be argued that
although the biliary sterol output is comparable to that
seen in wild-type mice that this is inappropriately low,
since the tissue and plasma pools of sitosterol are so
elevated in the knockout mice. Despite this caveat, the
findings of sitosterol in significant quantities in the bile
suggests that mechanisms other than via the sterolins can
'export' some of these sterols. Interestingly, although
humans who are heterozygous for genetic defects in either
ABCG5 or ABCG8 seem to be phenotypically normal,
mice heterozygous for Abcg8/sterolin-2 deficiency show
that sterol secretion is impaired, but not absent. Note that
under steady-state conditions on a rodent chow diet, het-
erozygous animals show no significant elevations in
plasma or tissue sitosterol levels, suggesting that the
activity of these proteins may not be rate limiting. Further-
more, the heterozygous Abcg8+/- mice showed higher lev-
els of biliary sitosterol relative to the wild-type mice.
While the rate of total biliary sterol secretion is reduced
compared to wild-type mice, since the heterozygous mice
are not sitosterolemic, either the activity of these proteins
is not rate limiting or other mechanisms can compensate
for a 50% loss of activity. On the other hand, since feeding
is intermittent, a slow, but continuous secretion during
post-prandial periods could easily negate any mild tem-
porary increase in tissue and plasma plant sterol levels in
heterozygous animals. This may be amenable to testing by
placing these animals on a high plant sterol diet and
measuring the plasma sterol levels.
Recently, Kosters et al. reported that Abcg5/Abcg8 mRNA
expression in a variety of different mouse strains corre-
lated with biliary cholesterol secretion rates [30]. In their
studies, although diosgenin-fed mice showed a marked
increase in biliary cholesterol output, mRNA levels of
Abcg5 and Abcg8 were not altered. Using Western blot
analyses, the protein level of Abcg5 was also not altered by
diosgenin, although Abcg8 was not measured. They con-
cluded that a parallel route for biliary cholesterol secre-
tion might be operational, independent of the sterolins.
While biliary cholesterol secretion is not completely
absent in the Abcg8-deficient mice it would appear that
sterolin-2 plays a major role in this process. In a genetic
screen of plasma plant sterol levels, Sehayek et al.
identified three loci that may be responsible for control-
ling plasma plant sterol levels and not one of these loci
mapped to the murine STSL region [43]. Thus, there is
support for at least four loci that may be involved in regu-
lating plasma plant sterol levels. To date the STSL locus isPage 18 of 21
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ficking and the identity of the others remains to be
elucidated.
We, as well as others, have proposed Abcg5/sterolin-1 and
Abcg8/sterolin-2 to function as obligate heterodimers.
Thus knocking out Abcg8/sterolin-2 alone is equivalent to
a functional loss of both sterolins. It has been shown that
Abcg8/sterolin-2 expression is required for correct apical
trafficking of Abcg5/sterolin-1 to the apical surface in a
polarized cell line and more recently in vivo by over-
expression experiments [18,19]. In experiments shown
here, using three separately developed anti-Abcg5/stero-
lin-1 antibodies, we have obtained inconsistent data
regarding the trafficking of Abcg5/sterolin-1 in Abcg8-/-
mice. Based upon classical N-glycosylation maturation it
would appear that Abcg5/sterolin-1, in the Abcg8-/- mice,
does not exit the endoplasmic reticulum. However, by
immunohistochemistry it appears that Abcg5/sterolin-1 is
apically expressed in the Abcg8-deficient mice regardless
of the anti-Abcg5/sterolin-1 antibody used. Interestingly,
in a report of Abcg5/Abcg8 localization in canine gall-
bladder epithelial cells, these two proteins were found
intracellularly under baseline conditions [44]. But when
given liver X receptor alpha (LXRα) agonist, Abcg5/stero-
lin-1 and Abcg8/sterolin-2 appeared to be expressed at the
apical surface. In these studies the UTSW anti-Abcg5/
sterolin-1 antibody was used. It is apparent with these
conflicting data that the trafficking of these transporters is
not as clear-cut. In a recent paper, Mangrivite et al. showed
that the apical sorting of rat SPNT in polarized renal
epithelial cells was independent of N-glycosylation [45].
Therefore, at this time, we can neither exclude the possi-
bility that Abcg5/sterolin-1 expression is functional in our
Abcg8/sterolin-2 deficient mice nor can we rule it out. We
have no functional assay for these proteins at present.
More extensive fractionation experiments are underway to
better determine the exact compartmental location of
Abcg5/sterolin-1 in the Abcg8-/- mice. In this context,
Plösch et al. have described an Abcg5/sterolin-1 deficient
mouse that maintains the ability to secrete biliary choles-
terol to the same extent as the wild-type mice and, when
fed a LXR agonist, had higher Abcg8 mRNA expression
and tended to secrete more biliary cholesterol than wild-
type mice [46]. It has been argued that Abcg5/sterolin-1
and Abcg8/sterolin-2 are dependent upon each other for
secretion of hepatic sterols into bile [19]. Given the data
presented here and from the Abcg5-deficient mouse this
does not appear to be the case. Perhaps in the previously
published model a non-physiologic state has been made
that generates these data. Taken together, these animal
models suggest that Abcg5/sterolin-1 and Abcg8/sterolin-
2 have independent function in vivo or that there are pro-
teins other than the sterolins that can secrete biliary
sterols.
Conclusions
The major findings in this study are: (1) disruption of
only one of the two genes comprising the STSL locus is
necessary and sufficient to cause sitosterolemia, (2) that
the loss of Abcg8/sterolin-2 leads to the loss of biliary cho-
lesterol secretion and (3) Abcg5/sterolin-1 appears to be
still apically-expressed despite the absence of Abcg8/stero-
lin-2. These data strongly support the direct role of Abcg8/
sterolin-2 as a key player in biliary cholesterol secretion,
although biliary sitosterol secretion was apparently pre-
served. These data suggest that there are mechanisms
other than Abcg8/sterolin-2 that allow for the secretion of
sitosterol into bile.
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